by Amy Guo, BS | August 6, 2020
Institutional policies and implicit biases have resulted in neglect at the point of care, higher rates of insurance loss, and a divestment of resources from diseases primarily impacting Black people. These inequities are evident in the past and present state of care in the US for sickle cell disease (SCD), an inherited blood disorder prevalent in those with sub-Saharan African or other malaria-endemic regional ancestry.
Read More
by Wadie D. Mahauad-Fernandez, PhD | August 6, 2020
The current model of medicine, which is based on the treatment of diseases via a “one-size-fits-all” approach, is outdated, inefficient, costly, and in some cases harmful. New technological and scientific discoveries have demonstrated that diseases are extremely heterogeneous and vary from one patient to another.
by Stella Belonwu, BS | June 14, 2019
Artificial intelligence (AI) is currently one of the biggest buzz words within technology innovation. In the simplest terms, AI is a branch of computer science that involves training computers
by Huiyang Winnie Liang, PhD | June 11, 2019
For pharmaceutical and life science companies, establishing successful collaborations with academic labs goes beyond identifying the right principal investigator (PI) or technology.
by Anthony Berger, PhD | January 31, 2019
I love talking about science. I independently taught undergraduate courses throughout my graduate program. Making basic science relevant to treating disease and improving lives was an exciting challenge.
by Peter Dykstra, M.S. | January 22, 2019
Entrepreneurship is a challenge. HBO’s hit show Silicon Valley characterizes the struggles of starting a startup in the Bay Area by highlighting the ups and downs of a nascent software company
by Nicholas Gentry, B.S. | January 17, 2019
You awaken and roll out of bed. Your alarm stops as it receives signals from your brain indicating wakefulness. Entering the bathroom, you turn on the lights and smart mirror in front of you with your thoughts.
by Sai Ganesan, PhD | October 15, 2018
Chronic pain affects 20% of the world population. The chronic pain drugs market is currently valued at $62 billion, with opioids leading the revenue contribution at 27%. Opioid analgesics have been the more effective class
by Jane Antony, PhD | October 15, 2018
Global oncology-related healthcare costs are estimated to surpass $150B by 2021, with an annual growth rate of 6-10%. While conventional therapies (e.g., chemotherapies, small molecule targeted therapies)
by Christin Schmidt, PhD | October 15, 2018
Pulling carbon dioxide (CO2) from the air to produce synthetic fuels will be the golden bullet in the fight against climate change and against a worldwide shortage of energy resources
